298 related articles for article (PubMed ID: 29118232)
1. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
2. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
3. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
[TBL] [Abstract][Full Text] [Related]
4. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
5. Health care utilization and costs by site of service for nonmetastatic breast cancer patients treated with trastuzumab.
Parthan A; Santos E; Becker L; Small A; Lalla D; Brammer M; Teitelbaum A
J Manag Care Spec Pharm; 2014 May; 20(5):485-93. PubMed ID: 24761820
[TBL] [Abstract][Full Text] [Related]
6. Measuring and predicting surgeons' practice styles for breast cancer treatment in older women.
Mandelblatt JS; Berg CD; Meropol NJ; Edge SB; Gold K; Hwang YT; Hadley J
Med Care; 2001 Mar; 39(3):228-42. PubMed ID: 11242318
[TBL] [Abstract][Full Text] [Related]
7. Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia.
Lee TY; Johnson A; Cooke CE; Yared JA; Summers A; Yang K; Liu S; Tang B; Onukwugha E
J Manag Care Spec Pharm; 2024 May; 30(5):430-440. PubMed ID: 38701030
[TBL] [Abstract][Full Text] [Related]
8. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Riley GF; Potosky AL; Klabunde CN; Warren JL; Ballard-Barbash R
JAMA; 1999 Feb; 281(8):720-6. PubMed ID: 10052442
[TBL] [Abstract][Full Text] [Related]
9. Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.
Hao Y; Li N; Fang AP; Koo V; Peeples M; Kageleiry A; Wu EQ; Guérin A
Adv Ther; 2016 Jun; 33(6):983-97. PubMed ID: 27216253
[TBL] [Abstract][Full Text] [Related]
10. Differences in Medicare Expenditures Between Appalachian and Nationally Representative Cohorts of Elderly Women With Breast Cancer: An Application of Decomposition Technique.
Vyas A; Madhavan SS; Sambamoorthi U
J Natl Compr Canc Netw; 2017 May; 15(5):578-587. PubMed ID: 28476737
[No Abstract] [Full Text] [Related]
11. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings.
Warren JL; Brown ML; Fay MP; Schussler N; Potosky AL; Riley GF
J Clin Oncol; 2002 Jan; 20(1):307-16. PubMed ID: 11773184
[TBL] [Abstract][Full Text] [Related]
12. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
Schonberg MA; Marcantonio ER; Li D; Silliman RA; Ngo L; McCarthy EP
J Clin Oncol; 2010 Apr; 28(12):2038-45. PubMed ID: 20308658
[TBL] [Abstract][Full Text] [Related]
14. Is There Variation in Procedural Utilization for Lumbar Spine Disorders Between a Fee-for-Service and Salaried Healthcare System?
Schoenfeld AJ; Makanji H; Jiang W; Koehlmoos T; Bono CM; Haider AH
Clin Orthop Relat Res; 2017 Dec; 475(12):2838-2844. PubMed ID: 28074438
[TBL] [Abstract][Full Text] [Related]
15. Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer.
Lipitz-Snyderman A; Sima CS; Atoria CL; Elkin EB; Anderson C; Blinder V; Tsai CJ; Panageas KS; Bach PB
JAMA Intern Med; 2016 Oct; 176(10):1541-1548. PubMed ID: 27533635
[TBL] [Abstract][Full Text] [Related]
16. Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.
Bynum J; Song Y; Fisher E
J Am Geriatr Soc; 2010 Apr; 58(4):674-80. PubMed ID: 20345867
[TBL] [Abstract][Full Text] [Related]
17. Managed care enrollment and chronically disabled women with breast cancer.
Habermann EB; Virnig BA; Durham SB; Baxter NN
Am J Manag Care; 2008 Aug; 14(8):514-20. PubMed ID: 18690767
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
19. How vertical integration affects the quantity and cost of care for Medicare beneficiaries.
Koch TG; Wendling BW; Wilson NE
J Health Econ; 2017 Mar; 52():19-32. PubMed ID: 28182998
[TBL] [Abstract][Full Text] [Related]
20. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
